Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by johnny007on Apr 06, 2022 1:25pm
148 Views
Post# 34581198

RE:WE ARE SAVED...

RE:WE ARE SAVED...Interesting, thank you Iain.
Yes, the volume is high compared to average traded, but too low to hint for a huge exit.
Float is only like 60% of OS - perhaps more?
Company valued below C$50M must be a practical joke, if not BK.

Most revenue came in from new acquired company, so this year will look much better revenue wise.
Since last PP was quite small, perhaps there is some light at the horizon,
but I get it - 'some' also call for the next one, rinse repeat.

Then the cancelled meeting, at least company is reacting to this 'attack'.

Rational:
- A very small PP of just C$1.87M was placed last time (almost bullish, they don't need more?)
- Offering SP C$0.187
- Warrant strike at C$0.2206 (what a number)

Hence C$0.2206 is the minimum goal, but to exercise it shall be above -> C$0.28, next resistance.

We will see. I am rather positive from this basement price.
<< Previous
Bullboard Posts
Next >>